Market revenue in 2023 | USD 152.1 million |
Market revenue in 2030 | USD 231.5 million |
Growth rate | 6.2% (CAGR from 2023 to 2030) |
Largest segment | Anti-bacterial |
Fastest growing segment | Anti-fungal |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Anti-bacterial, Anti-fungal, Corticosteroids, Others (Acaricidals, Cyclosporins) |
Key market players worldwide | Zoetis, Elanco Animal Health Inc, Dechra Pharmaceuticals, Merck & Co Inc, Vetoquinol SA, Virbac SA, CEVA Inc, Penn Veterinary Supply Inc, Vedco |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to companion animal ear infection treatment market will help companies and investors design strategic landscapes.
Anti-bacterial was the largest segment with a revenue share of 44.05% in 2023. Horizon Databook has segmented the Europe companion animal ear infection treatment market based on anti-bacterial, anti-fungal, corticosteroids, others (acaricidals, cyclosporins) covering the revenue growth of each sub-segment from 2018 to 2030.
Europe accounted for the second-largest market share in 2021, which is attributed to the strong local presence of several major players such as Ceva Santé Animale, Dechra Pharmaceuticals, Merial Animal Health, Virbac, Vetoquinol S.A., Zoetis, & Elanco, rapid acceptance of advanced veterinary devices, and large number of pet owners.
According to the European Pet Food Industry Federation, over 88 million households in Europe own a pet and annual sales of pet food products turnover was USD 24.06 billion. Europe’s companion animal ear infection treatment market includes the UK, Germany, France, Italy, and Spain, among other countries.
The European Medicines Agency (EMA) and its regulatory network partners have identified an action plan to improve and increase availability of animal medicines in Europe. There are other action plans being executed in the interest of animal and public health and animal welfare.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe companion animal ear infection treatment market , including forecasts for subscribers. This continent databook contains high-level insights into Europe companion animal ear infection treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account